Yu Kang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Transforming Growth Factor

Magnetic Resonance Imaging

Top Venues

Journal of gynecologic oncology

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Cancer immunology, immunotherapy : CII

Journal of ovarian research

This page only lists publications with an associated author ORCID identifier.

Publications

Kewei Zheng, Yi Gao, Cong-Jian Xu, Yu Kang
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis. Journal of gynecologic oncology 35 (4) (2024)
Kewei Zheng, Yi Gao, Cong-Jian Xu, Yu Kang
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis. Journal of gynecologic oncology 35 (4) (2024)
Kewei Zheng, Yi Gao, Cong-Jian Xu, Yu Kang
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis. Journal of gynecologic oncology 35 (4) (2024)
Jing Wang, Yan Du, Yu Kang
Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)
Kewei Zheng, Yi Gao, Cong-Jian Xu, Yu Kang
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis. Journal of gynecologic oncology 35 (4) (2024)
Jing Wang, Yan Du, Yu Kang
Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 165 (3) (2024)
Kewei Zheng, Yi Gao, Cong-Jian Xu, Yu Kang
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis. Journal of gynecologic oncology (2024)
Jing Wang, Yan Du, Yu Kang
Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 165 (3) (2024)
Yi Gao, Kewei Zheng, Mingyi Kang, Jing Xu, Yan Ning, Weiguo Hu, Ke Li, Yu Kang, Cong-Jian Xu
Establishment and characterization of a novel cell line (SCCOHT-CH-1) and PDX models derived from Chinese patients of small cell ovarian carcinoma of the hypercalcemic type. Human cell (2023)
Jing Xu, Yi Gao, Xiaotian Luan, Ke Li, Jing Wang, Yilin Dai, Mingyi Kang, Chong Lu, Minhua Zhang, Chris X Lu, Yu Kang, Congjian Xu
An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer. Cancer chemotherapy and pharmacology 89 (5) (2022)
Ke Li, Jing Xu, Jing Wang, Chong Lu, Yilin Dai, Qing Dai, Wang Zhang, Congjian Xu, Shu Wu, Yu Kang
Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer. Cancer immunology, immunotherapy : CII (2022)
Jing Wang, Jing Xu, Ke Li, Yunke Huang, Yilin Dai, Congjian Xu, Yu Kang
Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer. Journal of ovarian research 13 (1) (2020)